Literature DB >> 7631336

Effects of a specialized team on stroke care. The first two years of the Yale Stroke Program.

D J Webb1, P B Fayad, C Wilbur, A Thomas, L M Brass.   

Abstract

BACKGROUND AND
PURPOSE: Strategies have been proposed for stroke care to improve quality or reduce cost. We sought to document the effects of a new program of specialized stroke care.
METHODS: In a programmatic review using historical and concurrent control subjects, we evaluated patients discharged with a stroke diagnosis (diagnosis-related group 14) over a 6-year period between January 1987 and December 1992. Patients were from an academic medical center. The intervention was consultation (on university neurology patients) by a specialized multidisciplinary team during the last 2 years of the review period. The main outcome measures were median length of stay and rate of common complications before and after implementation compared with other hospital services (private neurology and medicine).
RESULTS: Stroke team involvement was associated with a shortened median length of stay from 10 to 8 days (P < .0001). There was no significant change in the median length of stay for the private neurology or medicine services. After stroke team involvement, there were fewer urinary tract infections (P = .056), and those patients who developed infection had a shorter length of stay (P = .0007). There was no change in the rate of aspiration pneumonia or in length of stay for patients with aspiration pneumonia. Mortality did not change.
CONCLUSIONS: A coordinated, multidisciplinary approach to stroke care may reduce length of stay and morbidity in patients hospitalized because of stroke.

Entities:  

Mesh:

Year:  1995        PMID: 7631336     DOI: 10.1161/01.str.26.8.1353

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

Review 1.  Medical therapy for acute ischemic stroke.

Authors:  L B Goldstein
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

2.  The role of neurocritical care: a brief report on the survey results of neurosciences and critical care specialists.

Authors:  Manjunath Markandaya; Katherine P Thomas; Babak Jahromi; Mathew Koenig; Alan H Lockwood; Paul A Nyquist; Marek Mirski; Romergryko Geocadin; Wendy C Ziai
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

3.  Stroke: non-motor sequelae, medical co-morbidity and patterns of intervention after referral to a special interest service.

Authors:  D R Collins; D O'Neill
Journal:  Ir J Med Sci       Date:  1998 Jan-Mar       Impact factor: 1.568

Review 4.  Controversies about tissue plasminogen activator: extending the window of therapy.

Authors:  S C Orr; C R Gomez
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

Review 5.  Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association.

Authors:  Daniel T Lackland; Edward J Roccella; Anne F Deutsch; Myriam Fornage; Mary G George; George Howard; Brett M Kissela; Steven J Kittner; Judith H Lichtman; Lynda D Lisabeth; Lee H Schwamm; Eric E Smith; Amytis Towfighi
Journal:  Stroke       Date:  2013-12-05       Impact factor: 7.914

Review 6.  Post-stroke infection: a systematic review and meta-analysis.

Authors:  Willeke F Westendorp; Paul J Nederkoorn; Jan-Dirk Vermeij; Marcel G Dijkgraaf; Diederik van de Beek
Journal:  BMC Neurol       Date:  2011-09-20       Impact factor: 2.474

7.  Access to Expert Stroke Care with Telemedicine: REACH MUSC.

Authors:  Abby Swanson Kazley; Rebecca C Wilkerson; Edward Jauch; Robert J Adams
Journal:  Front Neurol       Date:  2012-03-21       Impact factor: 4.003

8.  Costs of stroke and stroke services: Determinants of patient costs and a comparison of costs of regular care and care organised in stroke services.

Authors:  Job Van Exel; Marc A Koopmanschap; Jeroen DH Van Wijngaarden; Wilma JM Scholte Op Reimer
Journal:  Cost Eff Resour Alloc       Date:  2003-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.